Search results
Jacob Rees-Mogg claims UK government 'downplayed' risks of AstraZeneca COVID vaccine
Yahoo News UK· 9 hours agoThe European Medicines Agency's (EMA) "clear" conclusion following an investigation into 30 cases of...
AstraZeneca recalls Covid vax: Risk-benefit currently against further use, say experts
Investing.com· 3 days agoThe recall of its Covid-19 vaccine, made in collaboration with Oxford University, worldwide, comes...
AstraZeneca admits Covishield jab raises TTS risk. Should you be worried?
Investing.com· 2 weeks agoNew Delhi, April 30 (IANS) Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is...
Backlogged: Few cases finished after millions spent investigating COVID vaccine claims
WBRC Fox 6 Birmingham· 2 weeks agoOn the extremely rare occasions that a vaccine meant to protect public health harms a patient, the...
AstraZeneca Is Withdrawing Its Covid Vaccine Worldwide, Citing Low Demand
New York Times· 2 days agoThe shot is no longer being manufactured or supplied, and it is no longer authorized for use in...
Why autoimmune disorder lupus affect women more than men
Investing.com· 22 hours agoNew Delhi, May 10 (IANS) Female sex hormone oestrogen and the X chromosome play a significant role...
A Dutch man with lymphoma and other blood disorders was infected with the COVID-causing virus for...
Scientific American· 1 week agoWhen the Omicron strain of SARS-CoV-2, the virus that causes COVID, was surging around the world in...
Covid Vaccine Side Effects: 4 Takeaways From Our Investigation
New York Times· 1 week agoThousands of Americans believe they experienced rare but serious side effects. Apoorva Mandavilli...
MRNA vaccine effective in treating glioblastoma brain cancer in small trial
UPI· 1 week agoThe cancer vaccine is based on mRNA technology similar to that used in COVID-19 vaccines, but in...
Vax benefits outweigh risks of extremely rare potential side effects: AstraZeneca
Investing.com· 2 weeks agoThe company's response, in a statement to IANS, comes amidst furore over the company admitting in UK...